Search company, investor...

Bionaut Pharmaceuticals

Founded Year



Unattributed VC | Alive

Total Raised


Last Raised

$2.55M | 20 yrs ago

About Bionaut Pharmaceuticals

Bionaut Pharmaceuticals is a Healthcare/Pharmaceuticals / Drugs company based in Cambridge, Massachusetts. Bionaut Pharmaceuticals' investors include CHL Medical Partners and Healthcap Venture Capital.

Headquarters Location

One Broadway

Cambridge, Massachusetts, 02142,

United States


Missing: Bionaut Pharmaceuticals's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Bionaut Pharmaceuticals's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Bionaut Pharmaceuticals Frequently Asked Questions (FAQ)

  • When was Bionaut Pharmaceuticals founded?

    Bionaut Pharmaceuticals was founded in 2000.

  • Where is Bionaut Pharmaceuticals's headquarters?

    Bionaut Pharmaceuticals's headquarters is located at One Broadway, Cambridge.

  • What is Bionaut Pharmaceuticals's latest funding round?

    Bionaut Pharmaceuticals's latest funding round is Unattributed VC.

  • How much did Bionaut Pharmaceuticals raise?

    Bionaut Pharmaceuticals raised a total of $2.55M.

  • Who are the investors of Bionaut Pharmaceuticals?

    Investors of Bionaut Pharmaceuticals include CHL Medical Partners and HealthCap Venture Capital.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.